[General Electric GE HealthCare (Germany)] FinkAvenue/iStock Editorial via Getty Images GE HealthCare Technologies (GEHC [https://seekingalpha.com/symbol/GEHC]) is in advanced talks to acquire Sofie Biosciences for about $1 billion, a move that would expand its presence in radioactive diagnostic agents used with medical scans, the Financial Times reported Sunday, citing people familiar with the matter. The companies could announce a transaction as soon as next week, although negotiations may still change or fall apart. GE HealthCare (GEHC [https://seekingalpha.com/symbol/GEHC]), Sofie and private equity investor Trilantic declined or did not respond to requests for comment.
Mostramos publicamente o ponto principal. Crie uma conta gratuita para continuar lendo o artigo completo, salva-lo, comenta-lo e conecta-lo ao contexto de mercado e OSINT.